Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 3 subunit K (EIF3K) is the smallest and highly conserved subunit of the eukaryotic initiation factor 3 (eIF3) complex, which is essential for the initiation of protein synthesis in eukaryotic cells[1][3][6]. EIF3K contains a HEAT analogous motif (HAM) domain and a winged-helix (WH) domain, enabling protein-protein and RNA interactions within and beyond the eIF3 complex[1][3]. As part of eIF3, EIF3K binds the 40S ribosomal subunit, helping form the preinitiation complex and regulating mRNA recruitment—typically acting as a negative modulator of ribosomal protein synthesis and overall global translation[5][6]. EIF3K also influences cell cycle control, apoptosis (e.g., interacting with keratin 18 and caspases in epithelial cells), and cellular stress responses, as well as receptor trafficking mechanisms[1][2][5]. Depletion of EIF3K can promote cell proliferation, confer resistance to cellular stress, and may be linked to cancer biology based on its function as a translational repressor[5][7]. Disease associations include certain vascular disorders and relevance in tumor growth regulation[6]. No approved drugs directly target EIF3K, and its systemic regulatory roles present both therapeutic opportunities and challenges.
Most relevant literature describes EIF3K as a regulator of translation and cell proliferation; no approved drugs directly target EIF3K. Mechanisms in research include modulation of ribosomal protein production, influencing mRNA translation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 3 subunit K (EIF3K).